Homepage - RAPT Therapeutics
THE SCIENCE TO OVERCOME INFLAMMATORY AND IMMUNOLOGIC DISEASES Relentlessly focused on advancing treatments for patients with inflammatory and immunologic diseases RAPT …
Pipeline - RAPT Therapeutics
RAPT Therapeutics is focused on the development of therapies for patients with significant unmet needs in inflammatory and immunologic diseases. Utilizing our deep and proprietary expertise in …
About Us - RAPT Therapeutics
RAPT Therapeutics is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and …
RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial ...
Dec 31, 2024 · RAPT Therapeutics, Inc. (“RAPT” or the “Company”) is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel …
RAPT Therapeutics Announces Pricing of Public Offering of Common …
Oct 21, 2025 · RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and …
Science - RAPT Therapeutics
Our proprietary drug discovery and development engine has identified several immune drivers that have the ability to be “tuned down” to suppress an overactive immune response in inflammatory diseases. …
RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of ...
Oct 27, 2025 · RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and …
RAPT Therapeutics Reports Third Quarter 2025 Financial Results and ...
Sep 30, 2025 · RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and …
RAPT Therapeutics Reports Positive Initial Data from Ongoing Phase …
RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with …
RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial ...
Dec 31, 2023 · RAPT Therapeutics is a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients …